Alternatives to BioForge Therapeutics
BioForge Therapeutics is a HealthTech tool: developing novel gene therapies for rare genetic disorders. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest HealthTech companies to BioForge Therapeutics
- Website Majesty Therapeutics, .8Biotech
Developing novel therapies for rare genetic disorders and unmet medical needs.
- Website
Congenica38HealthTechCambridge, United Kingdom$73.8MGenomic data analysis platform for rare diseases and cancer.
- Website
LabCorp69HealthTechBurlington, United States$2.9BGlobal life sciences company providing diagnostic and biopharma laboratory services.
- Website
Moderna77BiotechnologyCambridge, United States$4.5BModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- Website
ScreenPoint Medical54HealthTechNijmegen, Netherlands$30.0MAI-powered breast cancer detection and risk assessment solutions.
- Website
Molecular Health54HealthTechHeidelberg, Germany$26.8MData-driven software solutions for precision medicine and pharmaceutical development.
- Website
Precision Medicine Group51HealthTechFranklin, United States$275.0MSpecialized services for pharmaceutical and life sciences clients across product development and commercialization.
- Website
Immunai69HealthcareNew York, United States$295.0MMapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.
- Website
Epicrispr Biotechnologies62BiotechnologySouth San Francisco, United States$90.0MEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
- Website LELexeo Therapeutics61BiotechNew York City, United States$495.0M
Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.
- Website
LifeMine Therapeutics Inc.60BiotechnologyWatertown, United States$543.0MClinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
- Website
Mana.bio59Life SciencesBoston, United States$19.5MAI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.
- Website
Spark Therapeutics58BiotechnologyPhiladelphia, United States$82.8MA biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.
- Website
Rocket Pharmaceuticals57BiotechnologyCranbury, USA$382.9MA biotechnology company developing genetic therapies for rare disorders.
- Website
FORE Biotherapeutics56HealthcarePhiladelphia, United States$232.4MPrecision oncology company developing cancer therapies guided by proprietary functional genomics.
- Website
Eleven Therapeutics56HealthcareLondon, United Kingdom$22.0MIsraeli-UK biotech company developing novel RNA therapeutics for rare genetic diseases.
- Website
Tenaya Therapeutics55BiotechSouth San Francisco, United States$158.5MBiotechnology company developing gene therapies and regenerative medicine for heart disease.
- Website
Adaptam Therapeutics53BiotechCambridge, United States$4.7MDeveloping novel therapeutics for rare genetic diseases with a focus on protein degradation.
- Website
Avidity Biosciences53BiotechSan Diego, United States$495.0MClinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.
- Website
Orchard Therapeutics51BiotechBoston, United States$125.0MGene therapy company developing treatments for rare inherited diseases.
Showing the 20 closest matches. See the rest on the BioForge Therapeutics profile.
Compare BioForge Therapeutics head to head
Side by side on what each one does, what it costs, and what real users report.